Shop By Brands
S
Shop By Brand
S
Home - SYNVISC®
SYNVISC® is injected directly into the intra-articular space of the knee by a qualified medical professional. The injection technique depends on the patient’s anatomy and the specific product being used.
Depending on the product format, either a single injection or a 3-injection series is recommended.
Each SYNVISC product is prefilled and ready for use under sterile conditions.
SYNVISC® is associated with minimal side effects, which are typically localized and resolve within a few days:
Serious reactions are rare and largely avoidable with proper patient selection and sterile administration.
Compared to other viscosupplements, SYNVISC® delivers a unique combination of viscosity, cushioning, and extended durability thanks to its proprietary hylan polymer formulation. While products like MONOVISC® and SUPARTZ® are effective, SYNVISC® provides both multi-dose and single-dose formats, offering flexibility for treatment planning.
Clinicians seeking to order SYNVISC ONE online benefit from simplified administration without compromising therapeutic outcome. Whether in single or three-dose formats, SYNVISC® remains a leading viscosupplement trusted by orthopedic professionals worldwide.
SYNVISC® is a hyaluronic acid-based viscosupplement used to treat osteoarthritis-related knee pain. It consists of hylan A and B polymers, derived from a highly purified bacterial fermentation process, which closely resemble the natural synovial fluid found in healthy joints.
Upon intra-articular injection, SYNVISC® restores the viscoelasticity of synovial fluid, enabling smoother joint movement and effective shock absorption. It reduces mechanical stress on the cartilage and minimizes pain through improved lubrication, enhancing overall joint function without systemic drug intervention.
SYNVISC® is indicated for the treatment of pain in osteoarthritis of the knee in patients who have not responded to conservative, non-pharmacologic therapy and simple analgesics. It is used to:
SYNVISC® supports the joint environment, particularly when endogenous hyaluronic acid levels are depleted.
SYNVISC® is one of the most extensively studied viscosupplements on the market, with a long history of global use. Its unique formulation and dual-polymer structure deliver extended joint protection and improved mobility for osteoarthritis patients.
Key benefits include:
Healthcare providers who buy SYNVISC rely on its consistent performance, safety, and global regulatory approvals.
Patients typically experience relief within a few weeks of the initial injection, with peak results emerging between 4 to 6 weeks post-treatment. The effects of a SYNVISC® injection may last up to six months, depending on the severity of osteoarthritis and patient activity levels.
Repeat treatments can be administered based on clinical evaluation.
SYNVISC® has a strong safety profile. Its high-purity, non-animal derived formulation reduces immunogenic risks and adverse reactions.
When administered under sterile conditions by trained professionals, SYNVISC® is well tolerated. Most side effects are mild and transient.